fig5
From: The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review
Figure 5. Basic oncogenic pathways in melanoma. BRAF mutations are mostly common and, in the end, lead to the expression of PD-L1. The PI3K pathway is usually activated simultaneously and is inhibited by PTEN.
